AIM ImmunoTech Inc. AIM
0.19
(0.01)
(5.00%)
as of 25 Sep
- Market cap
- $8.0M
- P/E
- 0.0×
Follow AIM
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
160.04 | 22.22 | 20.93 | 5.02 | 339.14 | 312.90 | 105.78 | 112.00 | 63.93 | 20.23 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(7.00) | (12.78) | (3.18) | (0.83) | (19.37) | (7.35) | (2.46) | (2.32) | (2.75) | (0.90) |
P/B ratio |
0.95 | 1.12 | 1.48 | 0.15 | 0.91 | 0.75 | 0.39 | 2.37 | 0.00 | 0.00 |
Price to Tangible BV |
1.01 | 1.24 | 1.80 | 0.17 | 0.94 | 0.78 | 0.42 | 3.13 | 0.00 | 0.00 |
EV/Sales |
96.29 | 21.60 | 22.82 | (1.69) | 112.79 | (43.54) | (130.77) | 51.01 | 42.57 | (1.51) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.33 | 0.94 | 0.00 | 0.00 | 0.01 |
EV/Operating CF |
(1.20) | (1.19) | (0.79) | 0.07 | (1.77) | 0.42 | 1.14 | (0.48) | (0.49) | 0.01 |
EV/FCF |
(1.13) | (1.18) | (0.86) | 0.07 | (1.68) | 0.41 | 1.48 | (0.46) | (0.47) | 0.01 |
Quick Ratio |
2.41 | 0.79 | 0.55 | 8.52 | 36.41 | 74.16 | 26.35 | 1.65 | 0.42 | 0.49 |
Current Ratio |
2.85 | 1.29 | 0.72 | 9.27 | 36.58 | 74.61 | 26.69 | 1.68 | 0.44 | 0.53 |
Net Debt/EBITDA |
0.47 | 0.03 | (0.07) | 0.22 | 2.61 | 2.67 | 1.70 | 0.41 | 0.21 | 0.22 |
Debt/Assets |
0.00% | 12.92% | 18.18% | 30.01% | 3.26% | 0.26% | 2.07% | 0.00% | 0.00% | 16.03% |
Debt/Equity |
0.00 | 0.21 | 0.49 | 0.46 | 0.03 | 0.00 | 0.02 | 0.00 | 0.00 | (0.09) |
Asset Turnover |
0.00 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Operating CF/Net income |
0.98 | 0.96 | 1.08 | 0.96 | 0.72 | 0.73 | 0.83 | 0.73 | 0.86 | 0.79 |
Capex/Depreciation |
(0.35) | (0.07) | 0.81 | (0.34) | (0.59) | (0.47) | 14.18 | (2.13) | (0.93) | (0.20) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (41.83%) | (68.25%) | (141.63%) | (105.44%) | (39.33%) | (32.77%) | (41.40%) | (122.42%) | (421.26%) | 251.38% | |
| (36.00%) | (49.93%) | (70.06%) | (54.36%) | (33.75%) | (31.28%) | (39.61%) | (96.75%) | (123.76%) | (194.00%) | |
ROIC |
(89.59%) | (84.63%) | (122.49%) | (71.40%) | (38.81%) | (134.40%) | (243.44%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(53.51%) | (88.01%) | (156.26%) | (57.22%) | (31.52%) | (35.69%) | (55.31%) | (480.22%) | 329.84% | 488.38% |
Average Days of Receivables |
0.00 | 20.05 | 1,088.04 | 2,137.86 | 2,516.93 | 4,436.78 | 4,338.58 | 2,139.41 | 0.00 | 29.03 |
Research and Development Expense of Revenue |
5,551.09% | 937.76% | 1,301.91% | 3,322.14% | 3,509.20% | 5,682.96% | 4,957.45% | 5,415.35% | 3,645.29% | 4,459.09% |
Selling, General and Administrative Expense of Revenue |
8,348.91% | 1,503.89% | 1,689.65% | 5,027.86% | 5,309.20% | 6,423.70% | 9,272.34% | 10,463.86% | 8,067.06% | 8,750.00% |
Intangible Assets out of Total Assets |
0.05 | 0.06 | 0.07 | 0.06 | 0.02 | 0.03 | 0.05 | 0.12 | 0.30 | 0.29 |
Share Based Compensation of Revenue |
445.65% | 130.66% | 253.13% | 609.29% | 635.58% | 1,161.48% | 676.60% | 120.30% | 403.53% | 68.18% |
Graham Net Nets |
0.24 | (0.21) | (0.63) | 1.64 | 0.67 | 1.17 | 2.30 | 0.24 | (0.53) | (6.89) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.57 | 38.13 |
Earnings Yield |
(52.82%) | (85.53%) | (126.16%) | (525.48%) | (28.80%) | (44.83%) | (128.87%) | (128.87%) | (159.79%) | (971.82%) |
Free Cash Flow Yield |
(53.30%) | (82.50%) | (126.49%) | (494.69%) | (19.83%) | (34.00%) | (83.77%) | (98.05%) | (142.00%) | (636.97%) |
Revenue per Share |
18.40 | 67.23 | 36.70 | 3.85 | 0.51 | 0.29 | 0.29 | 0.42 | 0.30 | 0.05 |
Operating CF per Share |
(1,476.00) | (1,221.69) | (1,064.00) | (249.09) | (32.56) | (29.50) | (33.52) | (43.77) | (26.58) | (6.77) |
Capex per Share |
(90.80) | (10.62) | 92.30 | (10.03) | (1.87) | (0.82) | 7.55 | (1.11) | (0.99) | (0.23) |
Free Cash Flow per Share |
(1,566.80) | (1,232.31) | (971.70) | (259.12) | (34.43) | (30.32) | (25.97) | (44.88) | (27.57) | (7.00) |
Cash per Share |
1,173.60 | 324.15 | 182.50 | 241.15 | 122.49 | 101.96 | 71.16 | 26.90 | 7.10 | 1.88 |
Shareholders Equity per Share |
3,099.60 | 1,338.92 | 517.40 | 369.29 | 192.51 | 120.15 | 80.06 | 21.06 | (2.36) | (6.04) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3,099.60 | 1,338.92 | 517.40 | 369.29 | 192.51 | 120.15 | 80.06 | 21.06 | (2.36) | (6.04) |
Free Cash Flow |
(7.83) | (8.01) | (9.72) | (9.43) | (10.96) | (14.35) | (12.48) | (21.80) | (15.44) | (11.33) |
Working Capital |
4.51 | 0.80 | (1.49) | 9.32 | 39.21 | 49.54 | 34.96 | 5.90 | (5.36) | (2.93) |
Capital Expenditures |
(0.45) | (0.07) | 0.92 | (0.36) | (0.59) | (0.39) | 3.63 | (0.54) | (0.56) | (0.38) |
Net Current Asset Value |
3.57 | (2.00) | (4.87) | 3.13 | 37.02 | 49.39 | 34.30 | 5.41 | (5.75) | (12.27) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.31 | 0.93 | 0.00 | 0.00 | 0.01 |
Capex to Sales |
4.93 | 0.16 | (2.51) | 2.61 | 3.65 | 2.87 | (25.74) | 2.66 | 3.27 | 4.30 |
Net Profit Margin |
(8,154.35%) | (1,889.93%) | (2,677.66%) | (6,717.14%) | (8,834.36%) | (14,168.15%) | (13,790.78%) | (14,337.62%) | (10,188.24%) | (15,861.36%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.12 | 0.15 | 0.15 | 0.16 | 0.20 | 1.31 | 1.98 | 5.51 | 26.76 |
Cash ROIC |
(79.07%) | (130.70%) | (193.59%) | (56.89%) | (16.45%) | (17.11%) | (22.18%) | (91.80%) | (564.82%) | 189.84% |
Accounts Receivable Turnover |
0.00 | 0.78 | 0.66 | 0.15 | 0.17 | 0.10 | 0.09 | 0.14 | 0.00 | 0.15 |
Accounts Payable Turnover |
1.06 | 1.45 | 1.24 | 1.55 | 1.89 | 2.93 | (1.47) | 0.01 | 0.00 | 0.03 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
292.20 | 228.63 | 280.77 | 192.92 | 173.44 | 85.02 | (324.54) | 55,992.74 | 75,154.68 | 4,648.05 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.56 | 0.56 | 0.96 | 0.97 | 1.38 | 1.66 | 1.43 | — | 0.60 |
Average Payables |
1.05 | 0.81 | 0.71 | 0.58 | 0.43 | 0.29 | 0.29 | 3.41 | 6.41 | 4.01 |
Average Assets |
20.84 | 16.54 | 14.03 | 17.30 | 42.67 | 61.14 | 49.09 | 29.93 | 13.99 | 7.20 |
Average Common Equity |
17.93 | 12.10 | 6.94 | 8.92 | 36.61 | 58.36 | 46.97 | 23.66 | 4.11 | (5.55) |
Columns are period end dates